Mesut Yılmaz

25PUBLICATIONS
127CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 12, 2026
Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysis.

|May 27, 2026
Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature.

|May 12, 2026
Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

|Mar 28, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

|Mar 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin, Fatih Kemik, Harun Muglu

|Jul 30, 2025
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy.

Rumeysa Colak, Caner Kapar, Ezgi Degerli

Pageof 5

Frequent Collaborators

9 joint publications

Rumeysa Colak

6 joint publications

Nargiz Majıdova

4 joint publications

Caner Kapar

4 joint publications

Özkan Alan